Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05185739 |
Title | Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) (PRIMER-1) |
Acronym | PRIMER-1 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University College, London |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Queen Elizabeth Hospital | NOT_YET_RECRUITING | Birmingham | United Kingdom | Details | ||
Cambridge University Hospitals NHS Foundation Trust | NOT_YET_RECRUITING | Cambridge | United Kingdom | Details | ||
Beatson West of Scotland Cancer Centre | NOT_YET_RECRUITING | Glasgow | United Kingdom | Details | ||
St James's Hospital, Leeds Teaching Hospital NHS Trust | NOT_YET_RECRUITING | Leeds | United Kingdom | Details | ||
Clatterbridge Cancer Centre | NOT_YET_RECRUITING | Liverpool | United Kingdom | Details | ||
King's College Hospital | NOT_YET_RECRUITING | London | United Kingdom | Details | ||
Royal Free Hospital | RECRUITING | London | United Kingdom | Details | ||
The Christie NHS Foundation Trust | NOT_YET_RECRUITING | Manchester | United Kingdom | Details | ||
Northern Institute of Cancer Research | NOT_YET_RECRUITING | Newcastle Upon Tyne | United Kingdom | Details |